Clinical Trial Update: Apatinib Combined With S-1 in the Second-line Treatment of Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

A phase 2 trial evaluating apatinib in combination with S-1 as second-line treatment for advanced pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Apatinib (apatinib)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Changzhou No.2 People's Hospital | Conditions: Advanced Pancreatic Cancer | Phase 2 | Status: UNKNOWN